Novartis AG
NVS | NYSE
$142.53
+$1.25 (+0.88%)
At close: Sep 23, 2026, 3:43 PM ET
$142.05
-$0.48 (-0.34%)
After-hours:
Sep 23, 2026, 5:29 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 28, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 3.27B | 3.16B | 2.41B | 3.93B | 4.02B | 3.61B | 2.82B | 3.19B | 3.25B | 2.69B | 2.68B | 1.51B | 2.27B | 2.29B | 1.47B | 1.33B | 1.7B | 2.22B | 16.31B | 2.76B | 2.9B | 2.06B |
Depreciation & Amortization | 1.2B | 1.23B | 1.55B | 1.36B | 1.26B | 1.15B | 1.63B | 1.97B | 1.16B | 1.31B | 1.61B | 3.11B | 1.71B | 2B | 1.95B | 1.92B | 1.8B | 1.41B | 1.52B | 1.45B | 1.44B | 1.7B |
Stock-Based Compensation | n/a | 303M | n/a | 268M | 267M | 262M | 272M | 255M | 257M | 260M | n/a | n/a | 222M | 190M | 197M | 208M | 204M | 203M | 195M | 173M | 185M | 183M |
Other Working Capital | 124.51M | -135M | -2.45B | 1.34B | 796M | -608M | -543M | 515M | 899M | -532M | -1.09B | 1.34B | 614M | -121M | -51M | 833M | 542M | -947M | 1.18B | 580M | 130M | -1.47B |
Other Non-Cash Items | 1.71B | -907M | 586.68M | -593M | 168M | -403M | -995M | -147M | -623M | -449M | 863.44M | -710M | -1.08B | -474M | -360M | 564M | -239M | -617M | -15.96B | -340M | -1.13B | -726M |
Deferred Income Tax | n/a | 683M | n/a | 266M | 507M | 798M | 465M | 200M | 595M | 441M | -1.88B | n/a | 403M | 446M | 275M | 257M | 347M | 450M | 645M | 472M | 611M | 391M |
Change in Working Capital | -285.19M | -787M | -2.29B | 1.34B | 442M | -1.77B | 5M | 824M | 238M | -1.99B | -737M | 1.47B | 55M | -1.5B | 585M | 447M | -54M | -2.01B | 1.18B | 409M | 130M | -1.47B |
Operating Cash Flow | 5.89B | 3.68B | 2.25B | 6.57B | 6.66B | 3.65B | 4.19B | 6.29B | 4.88B | 2.27B | 2.55B | 5.38B | 3.58B | 2.96B | 4.11B | 4.72B | 3.76B | 1.65B | 3.88B | 4.93B | 4.13B | 2.13B |
Capital Expenditures | -321.07M | -807M | -610.9M | -831M | -558M | -1.49B | -1.13B | -799M | -728M | -1.16B | -406M | -116M | -898M | -470M | -647M | -472M | -583M | -859M | -977M | -539M | -597M | -858M |
Cash Acquisitions | -2.28B | -12.04B | -1.17B | -160M | -1.68B | 6M | -264M | -50M | -3.33B | -263M | 156M | -3.39B | -86M | -42M | -11M | 6M | -61M | -839M | 20.33B | -17M | -2M | -211M |
Purchase of Investments | -46M | -54M | -81.13M | -100M | -58M | -55M | -2.31B | -1.01B | -282M | -50M | -576M | -39M | -30M | -107M | -10.58B | -6.71B | -13.27B | -4.26B | -15.63B | -807M | -87M | -86M |
Sales Maturities Of Investments | -226.6M | 1.17B | 69.64M | 179M | 50M | 1.88B | 581M | 1.47B | 1.08B | 569M | 179M | 289M | 50M | 11.08B | 9.66B | 12.46B | 2.15B | 15.22B | 689M | 22M | 246M | 1.8B |
Other Investing Acitivies | 218.48M | -459M | 88.38M | -425M | -226M | -1.24B | -487M | -466M | -411M | -928M | -88M | 787M | -762M | 162M | -142M | -340M | -186M | -503M | -364M | -79M | 261M | 132M |
Investing Cash Flow | -3.09B | -11.74B | -2.11B | -860M | -2.24B | 330M | -3.03B | -374M | -3.21B | -899M | -1.11B | -2.86B | -1.05B | 10.62B | -1.47B | 5.2B | -11.63B | 9.37B | 4.56B | -1.23B | 97M | 780M |
Debt Repayment | 2.15B | 11.57B | 3.37B | -511M | 181M | -523M | -106M | 2.51B | 892M | 1.15B | 674M | -443M | -774M | 933M | -1.27B | -2.01B | 331M | 404M | -3.05B | -1.26B | -2.37B | 755M |
Common Stock Repurchased | -1.2B | -1.88B | -1.48B | -2.3B | -2.71B | -2.72B | -2.76B | -2.85B | -1.62B | -1.1B | -1.25B | -1.63B | -2.96B | -2.89B | -2.68B | -2.72B | -2.71B | -2.54B | -148M | -284M | -703M | -1.92B |
Dividend Paid | -2.87B | -6.2B | 10.14M | 29.8M | -2.49B | -5.33B | n/a | n/a | -2.42B | -5.21B | n/a | n/a | n/a | -7.26B | n/a | n/a | n/a | -7.51B | n/a | n/a | n/a | -7.37B |
Other Financial Acitivies | -134.3M | 78M | -197.52M | -5.8M | -195M | 24M | -128M | -38M | -84M | -11M | -25M | 1.24B | 94M | 6M | -44M | -7M | 81M | 116M | -57M | 10M | 135M | -5M |
Financial Cash Flow | -2.03B | 3.58B | 1.71B | -2.79B | -5.21B | -8.55B | -3B | -382M | -3.2B | -5.16B | -607M | -832M | -3.64B | -9.2B | -3.99B | -4.74B | -2.3B | -9.53B | -3.25B | -1.53B | -2.94B | -8.54B |
Net Cash Flow | 739.02M | -4.56B | 1.88B | 2.9B | -410M | -4.39B | -2.15B | 5.71B | -1.57B | -3.92B | 987.97M | 1.52B | -1.12B | 4.48B | -1.21B | 5.1B | -10.23B | 1.45B | 5.2B | 2.09B | 1.32B | -5.86B |
Free Cash Flow | 5.57B | 2.87B | 1.64B | 5.74B | 6.11B | 2.15B | 3.06B | 5.49B | 4.15B | 1.11B | 2.14B | 5.26B | 2.68B | 2.49B | 3.46B | 4.25B | 3.17B | 790M | 2.91B | 4.39B | 3.54B | 1.27B |
Adj. Free Cash Flow | 5.57B | 2.57B | 1.64B | 5.47B | 5.84B | 1.89B | 2.79B | 5.23B | 3.89B | 849M | 2.14B | 5.26B | 2.46B | 2.3B | 3.27B | 4.04B | 2.97B | 587M | 2.71B | 4.21B | 3.35B | 1.09B |
Maintenance CapEx | -321.07M | -807M | -610.9M | -526.34M | -53.49M | -1.11B | -643.14M | -503.33M | -419.46M | -862.24M | -406M | n/a | -898M | -470M | -647M | -472M | -583M | -821.78M | -821.97M | -277.78M | -70.15M | -858M |
Growth CapEx | n/a | n/a | n/a | -304.66M | -504.51M | -385.32M | -487.86M | -295.67M | -308.54M | -293.76M | n/a | -116M | n/a | n/a | n/a | n/a | n/a | -37.22M | -155.03M | -261.22M | -526.85M | n/a |
Owner Earnings | 5.57B | 2.87B | 1.64B | 6.04B | 6.61B | 2.54B | 3.55B | 5.78B | 4.46B | 1.4B | 2.14B | 5.38B | 2.68B | 2.49B | 3.46B | 4.25B | 3.17B | 827.22M | 3.06B | 4.65B | 4.06B | 1.27B |
Add to Watchlist
Select watchlists to add or remove NVS